| In millions, except per share items | Dec-31-22 | Dec-31-21 |
| | 10-K | S-1/A |
| Revenues: |
| US | 11.1 | |
| Revenue from Rights Concentration Risk | 13.1 | |
| Europe | 1,965.0 | |
| Total revenues | 13.1 | 0.0 |
| Cost of goods sold | 2.9 | 0.0 |
| Gross profit | 10.2 | 0.0 |
| Gross margin | 78.1% | |
| Selling, general and administrative [+] | 54.0 | 4.9 |
| Sales and marketing | 6.3 | |
| General and administrative | 47.6 | 4.9 |
| Research and development | 60.0 | |
| EBITDA [+] | -96.7 | |
| EBITDA growth | 1871.2% | |
| EBITDA margin | -737.9% | |
| Depreciation and amortization | 7.0 | |
| EBIT [+] | -103.7 | -4.9 |
| EBIT growth | 2014.3% | |
| EBIT margin | -791.5% | |
| Non-recurring items [+] | 5.4 | |
| Asset impairment | 5.4 | |
| Interest expense, net [+] | 2.9 | |
| Interest expense | 5.3 | |
| Interest income | 2.4 | |
| Other income (expense), net [+] | 40.4 | -18.3 |
| Gain (loss) on investments | | 0.0 |
| Change in fair value of warrants | 22.1 | -17.8 |
| Change in value of contingent liability | 19.2 | |
| Pre-tax income | -71.5 | -23.2 |
| Income taxes | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% |
| Net income | -71.5 | -23.2 |
| Net margin | -545.9% | |
| |
| Basic EPS [+] | ($0.70) | ($0.62) |
| Growth | 11.9% | |
| Diluted EPS [+] | ($0.70) | ($0.62) |
| Growth | 12.4% | |
| |
| Shares outstanding (basic) [+] | 102.3 | 37.1 |
| Growth | 175.9% | |
| Shares outstanding (diluted) [+] | 102.3 | 37.3 |
| Growth | 174.5% | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |